IDiyas

For the Inventor, By the Inventor

Milan, Italy

Daniele Ciceri

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal10 out of 212 
 
Indena S.p.a.
 patents

Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 12404282 - Process for the purification of indole carbazole alkaloids (2025-09-02),
2. 11214543 - Process for the preparation of Lenvatinib (2022-01-04),
3. 10905657 - Solid dispersions of Coenzyme Q (2021-02-02),
4. 10717715 - Solid forms of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) and method for preparing the same (2020-07-21),
5. 9688625 - Amorphous form of a thiocolchicine derivative (2017-06-27),
6. 9586919 - Crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof (2017-03-07),
7. 9127018 - Solid forms of ortataxel (2015-09-08),
8. 9062018 - Crytalline form of 13-[(N-tert-butoxycarbonyl)-2'-O-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin III (2015-06-23),
9. 8106231 - Process for the preparation of (2R,3S)-3-phenylisoserine methyl ester acetate salt (2012-01-31),
10. 7232916 - Process for the preparation of a taxane derivative (2007-06-19),

Title: The Innovative Mind of Daniele Ciceri

Introduction

Daniele Ciceri, an accomplished inventor based in Milan, Italy, has made significant contributions to the field of pharmaceutical innovation. With a remarkable portfolio of nine patents, Ciceri exemplifies the spirit of creativity and dedication found in today's inventors. His work primarily revolves around novel processes and formulations that enhance drug delivery and effectiveness.

Latest Patents

Ciceri's most recent inventions include a patented process for the preparation of Lenvatinib, a key pharmaceutical compound. This inventive process involves synthesizing Lenvatinib using 4-amino-3-chloro-phenol and 4-chloro-7-methoxyquinoline-6-carboxamide, offering a method that could potentially streamline its production. Additionally, he has developed a solid dispersion comprising Coenzyme Q and a phospholipid, combined with various excipients such as cellulosic derivatives and polymeric materials. This invention aims to improve the bioavailability and stability of Coenzyme Q in pharmaceutical formulations.

Career Highlights

Daniele Ciceri is currently employed at Indena S.p.A., a company renowned for its expertise in the development and production of active pharmaceutical ingredients derived from plants. His innovative work at Indena is a testament to his commitment to advancing healthcare solutions through scientific research and development.

Collaborations

Throughout his career, Ciceri has had the opportunity to collaborate with talented professionals in the field. Notable coworkers include Federico Peterlongo and Andrea Gambini, who share a similar passion for innovation and contribute to the dynamic environment at Indena. Their collective efforts facilitate the progression of groundbreaking projects that can impact the pharmaceutical landscape.

Conclusion

Daniele Ciceri is an exemplary figure in the realm of pharmaceutical inventions. His recent patents reflect his dedication to improving drug formulation and delivery systems. As a key member of Indena S.p.A., Ciceri continues to foster innovation, pushing the boundaries of what is possible in the healthcare industry. With his impressive portfolio and collaborative spirit, the future undoubtedly holds more exciting developments from this talented inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…